Bioreactors Market: Current Analysis and Forecast (2021-2027)

The bioreactor market is expected to register a CAGR of around 7% over the period of 2021-2027. A bioreactor is defined as a manufactured device or vessel in which a biological reaction is carried out and used to grow a variety of organisms such as yeast, bacteria, and animal cells in the appropriate environment. They form a sustainable environment for cell growth and product formation. Bioreactors are used in the pharmaceutical and biotechnology industries to produce vaccines, antibodies, or biological products. They are also used in industrial processes for culturing organisms under controlled conditions and producing medicines for the treatment of chronic diseases. The growing adoption of a bioreactor can be attributed to the rising prevalence of various chronic diseases such as cardiovascular diseases, cancer, and diabetes coupled with a rapidly growing geriatric population which will increase the demand for therapeutics. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderlies is expected to double again by 2050 and reach nearly 2.1 billion worldwide. Furthermore, the bioreactor market is anticipated to grow on account of the growing technological advancement, and demand for enhancing lab efficiency.

BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, Thermo Fisher Scientific, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with advanced bioreactors.

Insights Presented in the Report

"Amongst Material Type, the single-use category accounted for the majority share in the market in 2020"

Based on material type, the market is classified into glass, stainless steel, and single-use. Amongst material types, the single-use category accounted for a significant share of the market owing to the advantages offered by these types of bioreactors such as the reduced need for cleaning and sterilization, and reduced risk of cross-contamination. Further, the adoption of single-use technologies is also due to its additional benefits such as proper mixing of cells, efficiency in air and gas transfer, and flexible operating conditions to enhance outcomes.

"Among Control Type, the automated is expected to witness highest CAGR during the forecast period"

Based on control type, the market is categorized into manual and automated. Among these, the automated segment is expected to witness the highest CAGR during the forecast period. The growing preference for mass flow controllers among the end-users has led to the use of automated control types. They are used to ensure additional safety and reduce the operating costs of the bioreactor.

"Amongst Usage, the pilot-scale production category accounted for the majority share in the market in 2020"

Based on usage, the market is classified into lab-scale production, pilot-scale production, and full-scale production. Amongst usage, the pilot-scale production category accounted for a significant share in the market due to development in the pharmaceutical and biotechnology industry, the surge in adoption of cell culture techniques, advancement in R&D activities for the production of personalized medicine, and an increase in the number of clinical and pre-clinical trial studies.

"Amongst End-User, the R&D department and institutes category accounted for the majority share in the market in 2020"

Based on end-users, the market is classified into R&D departments and institutes, CROs (contract research organizations), biopharmaceuticals companies and manufacturing, and CMOS (contract manufacturing organizations). Amongst end-users, the R&D department and institutes category accounted for a significant share in the market due to the development of novel & innovative systems, and the increasing adoption of advanced technologies to ease complex manufacturing. In addition, the expanding biopharmaceutical spending in developing countries will further boost product demand.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the bioreactor market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the bioreactor market industry in 2020 owing to an increase in the number of biomanufacturing facilities and huge investments in the biologics sector.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

• The report presents a quick review of overall industry performance at one glance.

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

Global bioreactor market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.